Literature DB >> 17320447

Five-year predictive factors of type 2 diabetes in men with impaired fasting glucose.

P Lecomte1, S Vol, E Cacès, C Born, C Chabrolle, G Lasfargues, J-M Halimi, J Tichet.   

Abstract

AIM: The outcome of 743 French men (age 20-60) with impaired fasting glucose (IFG) [blood glucose 6.1-6.9 mmol/l] at T1 was evaluated 5 years later, at T2.
METHODS: Personal and family medical history, smoking, nutritional habits, physical activity, blood pressure, body mass index (BMI) and waist girth, fasting biological data were collected at T1 and T2. Predictive factors for developing diabetes were compared between those who returned to normal fasting glucose and those who had diabetes, before and after adjustment for age, BMI, glucose and triglyceride (TG) levels.
RESULTS: At T2, 44%, 39%, 17% were classified as normal fasting plasma glucose (FPG), IFG or diabetic, respectively. Odd ratios for diabetes were 4.2 for men with a family history of diabetes (FHD), 3.4 if BMI > or = 25 kg/m(2), 2.9 if waist girth > or = 90 cm, 2.8 if TG > or = 2 mmol/l and 1.9 if no daily dairy products were eaten. Still significant after adjustment for age, BMI, glucose and TG levels were: FHD (P=0.001), no daily dairy products (P=0.001), high alcohol intake (P=0.02) and low physical activity (P = 0.02).
CONCLUSION: No daily dairy products, high alcohol intake and low physical activity were independent predictive factors of a 5-year onset of diabetes after adjusting for BMI, FHD, triglyceride and glucose levels at baseline. For a better prevention of diabetes, these findings give clues for behaviour modifications as soon as IFG is detected.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17320447     DOI: 10.1016/j.diabet.2006.11.009

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  8 in total

Review 1.  Whole grain and refined grain consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies.

Authors:  Dagfinn Aune; Teresa Norat; Pål Romundstad; Lars J Vatten
Journal:  Eur J Epidemiol       Date:  2013-10-25       Impact factor: 8.082

Review 2.  Physical activity and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis.

Authors:  Dagfinn Aune; Teresa Norat; Michael Leitzmann; Serena Tonstad; Lars Johan Vatten
Journal:  Eur J Epidemiol       Date:  2015-06-20       Impact factor: 8.082

3.  Adiponectin is Associated with Impaired Fasting Glucose in the Non-Diabetic Population.

Authors:  Sang Yeun Kim; Sun Ju Lee; Hyoun Kyoung Park; Ji Eun Yun; Myoungsook Lee; Jidong Sung; Sun Ha Jee
Journal:  Epidemiol Health       Date:  2011-08-20

Review 4.  Association between consumption of dairy products and incident type 2 diabetes--insights from the European Prospective Investigation into Cancer study.

Authors:  Nita G Forouhi
Journal:  Nutr Rev       Date:  2015-08       Impact factor: 7.110

5.  Determinants of Change in Glycemic Status in Individuals with Prediabetes: Results from a Nationwide Cohort Study in Germany.

Authors:  Rebecca Paprott; Christa Scheidt-Nave; Christin Heidemann
Journal:  J Diabetes Res       Date:  2018-10-14       Impact factor: 4.011

6.  Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR).

Authors:  Beverley Balkau; Céline Lange; Leopold Fezeu; Jean Tichet; Blandine de Lauzon-Guillain; Sebastien Czernichow; Frederic Fumeron; Philippe Froguel; Martine Vaxillaire; Stephane Cauchi; Pierre Ducimetière; Eveline Eschwège
Journal:  Diabetes Care       Date:  2008-08-08       Impact factor: 17.152

7.  The prevalence and determinants of impaired fasting glucose in the population of Taiwan.

Authors:  Chen-Mei Chen; Mei Chang Yeh
Journal:  BMC Public Health       Date:  2013-12-05       Impact factor: 3.295

8.  Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.

Authors:  Bernd Richter; Bianca Hemmingsen; Maria-Inti Metzendorf; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.